What Our Partners Say

We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us.

Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.

See more

Boehringer Ingelheim Venture Fund

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.